Search

Search Results
Results 68611 - 68620 of 68860 for Activity
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Abyraz
    Drug - 19 Jul 2022
    Consumer Medicine Information (CMI) about Abyraz intended for persons living in Australia.
  • Monodur
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Monodur intended for persons living in Australia.
  • Imdur
    Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Imdur intended for persons living in Australia.
  • DBL Papaverine Hydrochloride
    Drug - 23 Mar 2022
    Consumer Medicine Information (CMI) about DBL Papaverine Hydrochloride intended for persons living in Australia.
  • The Power of Digitalization in the Life Sciences and Diagnostics Sectors
    News - 19 Nov 2021
    In this interview, News-Medical talks to Frank Buescher and Wael Yared about the increasing digitalization of the life sciences and diagnostics sectors and the possibilities this entails.
  • Pavtide Accuhaler
    Drug - 20 Oct 2021
    Consumer Medicine Information (CMI) about Pavtide Accuhaler intended for persons living in Australia.
  • Seretide
    Drug - 17 Sep 2021
    Consumer Medicine Information (CMI) about Seretide intended for persons living in Australia.
  • Vectibix
    Drug - 9 Sep 2021
    Consumer Medicine Information (CMI) about Vectibix intended for persons living in Australia.
  • Betmiga
    Drug - 21 Jul 2021
    Consumer Medicine Information (CMI) about Betmiga intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback